Acute Porphyria Drug Database

Monograph

S02CA02 - Flumetasone and Antiinfectives
Propably not porphyrinogenic
PNP

Rationale
Probably no significant metabolic load.
Chemical description
Ear drops with moderately strong glucocorticoid (flumethasone: NP) combined with antibiotic/ antimycotic Vioform (cliochinol 10 mg/mL, no data on metabolism: PSP). Less than 5% of the dose is absorbed.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes S02C / S02CA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Locacorten-Vioform · Locacorten-Vioform, oordruppels
United Kingdom
Flumetasone · Flumetasone 0.02% / Clioquinol 1% ear drops · Locorten Vioform · Locorten Vioform ear drops
Denmark
Locacorten-Vioform
Finland
Locacorten-Vioform
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙